Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression

NCT06419608 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: BHV-7000
DRUG: Placebo

Sponsor

Biohaven Therapeutics Ltd.